Paradigm Asset Management Co. LLC Has $1.94 Million Stock Holdings in CVS Health Co. (NYSE:CVS)

Paradigm Asset Management Co. LLC cut its position in CVS Health Co. (NYSE:CVSFree Report) by 3.1% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 24,600 shares of the pharmacy operator’s stock after selling 800 shares during the period. Paradigm Asset Management Co. LLC’s holdings in CVS Health were worth $1,942,000 at the end of the most recent reporting period.

Several other hedge funds also recently bought and sold shares of CVS. Atticus Wealth Management LLC raised its stake in shares of CVS Health by 149.0% in the 4th quarter. Atticus Wealth Management LLC now owns 366 shares of the pharmacy operator’s stock valued at $29,000 after purchasing an additional 219 shares during the period. USA Financial Formulas lifted its stake in CVS Health by 573.2% in the 4th quarter. USA Financial Formulas now owns 377 shares of the pharmacy operator’s stock valued at $30,000 after acquiring an additional 321 shares in the last quarter. Cornerstone Planning Group LLC boosted its position in CVS Health by 111.5% during the 3rd quarter. Cornerstone Planning Group LLC now owns 461 shares of the pharmacy operator’s stock worth $32,000 after acquiring an additional 243 shares during the last quarter. ZRC Wealth Management LLC raised its holdings in shares of CVS Health by 400.0% in the fourth quarter. ZRC Wealth Management LLC now owns 500 shares of the pharmacy operator’s stock valued at $39,000 after purchasing an additional 400 shares during the last quarter. Finally, Northwest Financial Advisors bought a new stake in shares of CVS Health in the fourth quarter worth $42,000. 80.66% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

CVS has been the subject of a number of analyst reports. Leerink Partnrs downgraded shares of CVS Health from an “outperform” rating to a “market perform” rating in a research report on Wednesday, May 1st. Wells Fargo & Company decreased their price objective on CVS Health from $76.00 to $60.00 and set an “equal weight” rating for the company in a report on Tuesday, May 7th. Royal Bank of Canada decreased their price objective on CVS Health from $86.00 to $84.00 and set an “outperform” rating for the company in a report on Thursday, February 8th. StockNews.com cut CVS Health from a “buy” rating to a “hold” rating in a report on Thursday, February 15th. Finally, Cantor Fitzgerald cut CVS Health from an “overweight” rating to a “neutral” rating and reduced their price target for the stock from $87.00 to $58.00 in a report on Wednesday, May 1st. Nine investment analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. Based on data from MarketBeat, CVS Health has an average rating of “Moderate Buy” and a consensus target price of $76.75.

Get Our Latest Stock Analysis on CVS Health

CVS Health Price Performance

NYSE:CVS traded down $0.11 during mid-day trading on Monday, reaching $55.54. The stock had a trading volume of 11,725,700 shares, compared to its average volume of 12,009,923. The stock has a 50-day simple moving average of $67.13 and a two-hundred day simple moving average of $71.94. The stock has a market capitalization of $69.72 billion, a PE ratio of 9.76, a P/E/G ratio of 0.53 and a beta of 0.56. The company has a debt-to-equity ratio of 0.78, a current ratio of 0.81 and a quick ratio of 0.61. CVS Health Co. has a 12 month low of $53.70 and a 12 month high of $83.25.

CVS Health (NYSE:CVSGet Free Report) last posted its earnings results on Wednesday, May 1st. The pharmacy operator reported $1.31 earnings per share for the quarter, missing analysts’ consensus estimates of $1.69 by ($0.38). The company had revenue of $88.44 billion for the quarter, compared to the consensus estimate of $89.33 billion. CVS Health had a return on equity of 13.53% and a net margin of 2.03%. The business’s quarterly revenue was up 3.7% compared to the same quarter last year. During the same period in the previous year, the firm posted $2.20 EPS. On average, equities analysts anticipate that CVS Health Co. will post 7.02 earnings per share for the current year.

CVS Health Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Wednesday, May 1st. Shareholders of record on Monday, April 22nd were paid a dividend of $0.665 per share. The ex-dividend date was Friday, April 19th. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.79%. CVS Health’s payout ratio is presently 46.75%.

Insiders Place Their Bets

In related news, Director Edward J. Ludwig acquired 1,000 shares of the firm’s stock in a transaction that occurred on Thursday, May 2nd. The stock was acquired at an average cost of $53.88 per share, for a total transaction of $53,880.00. Following the completion of the acquisition, the director now directly owns 21,630 shares of the company’s stock, valued at approximately $1,165,424.40. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Insiders own 0.24% of the company’s stock.

About CVS Health

(Free Report)

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.

Featured Articles

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Co. (NYSE:CVSFree Report).

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.